SITE009-0182

SITE009 (AUS) › SITE009-0182

SITE009-0182

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE009 (AUS) · Dr. Novak
consented 2026-03-30

enrolled

AEs

3

Serious

0

Dropout signal

–

Adverse events

3

Grade 3 Anaemia — outcome: RECOVERED/RESOLVED; onset 2023-01-10 (study day 91); relationship: not assessed

severe assessed

Grade 1 Nausea — outcome: RECOVERED/RESOLVED; onset 2022-11-11 (study day 31); relationship: NOT RELATED

mild assessed

Grade 2 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2022-10-24 (study day 13); relationship: NOT RELATED

moderate assessed

Data queries

0

No data queries. Open queries would appear here for this patient.